Availability: In Stock
Darzalex (Daratumumab) is a prescription medicine used to treat a certain type of cancer (multiple myeloma). Daratumumab belongs to a class of drugs known as monoclonal antibodies. Daratumumab works by slowing or stopping the growth of cancer cells.
Daratumumab (Darzalex) manufacturted by JANSSEN-CILAG Pharma Ltd. In SWITZERLAND.
Daratumumab this medication is given by injection into a vein by a health care professional. It is given as directed by your doctor on a treatment schedule, usually once a week for the first 6 to 9 weeks (depending on your medical condition).
Side Effects
The most common adverse reactions of DARATUMUMAB are:
Tiredness, back pain, joint pain, diarrhea, or loss of appetite.
The above information comes from the Internet. Please consult with doctor for medical advice.